Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Dec 17, 2015
Sepsis affects millions of people worldwide and is increasing in incidence, yet there’s no effective way to mitigate the inflammatory response once it’s started. At the 2015 Boston Children’s Hospital Global Pediatric Innovation Summit + Awards, Brian McAlvin, MD, a critical care intensivist at Boston Children’s Hospital, introduces the audience to a technology called an Antibody Modified Conduit (AMC). By filtering inflammatory molecules from the circulation, AMCs can cure SIRS, the underlying mechanism for a variety of diseases including sepsis.